| BIOGEN INC. DL -,0005 | 215.050 / -0.26% |
| Date/Time | 04/23 / 07:41 |
| Chg. / Chg.(%) | -0.550 / -0.26% |
| Bid | 215.050 |
| Ask | 216.300 |
| Open | 215.600 |
| Previous Close | 215.600 |
| High | 215.600 |
| Low | 215.050 |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | 7 |
| ISIN | US09062X1037 |
| Security | IDP |
| Exchange | Lang & Schwarz |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 215.050 |  |
|
| NASDAQ | 259.0000 |  |
2,411,329 |
| IEX | 260.64 | |
90,320 |
| Cboe US | 259.14 | |
82,177 |
| Xetra | 218.05 | |
5,880 |
| London Inter.. | 261.59 | |
4,779 |
| Moscow | 19,670.00 | 3,794 | |
| TradeGate | 215.950 | |
2,541 |
| Stuttgart | 217.400 | |
765 |
| Vienna Globa.. | 217.80 | |
512 |
| gettex | 217.250 | |
233 |
| Frankfurt | 218.1500 | |
55 |
| Mexico | 5,060.01 | |
11 |
| Hamburg | 215.90 | |
5 |
| München | 222.65 | |
0 |
| Düsseldorf | 219.40 | |
0 |
| Berlin | 218.45 | |
0 |
| Hannover | 222.70 | |
0 |
News
- Biogen revenue drops 24% to $2.69B in Q1
04/22/2021 / 13:11 - TeleTrader - Abeona Therapeutics Appoints Two Industry Leaders as New Independent Members to Its Board of Directors
04/19/2021 / 13:30 - GlobeNewswire - Biogen Advances Leading Research in Spinal Muscular Atrophy (SMA) with New Data at AAN 2021 Exploring Opportunities to Improve Outcomes for Patients
04/19/2021 / 13:30 - GlobeNewswire - New Data at AAN 2021 from Across Biogen’s MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis
04/16/2021 / 13:30 - GlobeNewswire - Biogen Grows Presence in China with the Approval of TECFIDERA® (dimethyl fumarate) for the Treatment of Relapsing Multiple Sclerosis
04/15/2021 / 22:30 - GlobeNewswire
Real-time